Respiratory Nursing: Tuberculosis Care

Tuberculosis (TB) remains a significant global health threat, and nursing care is central to its management and control. Effective TB nursing bridges the gap between complex medical treatment and successful patient outcomes, requiring a dual focus on rigorous infection prevention and meticulous therapeutic support. Your role is critical in breaking the chain of transmission, ensuring treatment completion, and safeguarding public health.

Understanding Tuberculosis: Pathophysiology and Transmission

Tuberculosis is caused by the bacterium Mycobacterium tuberculosis, which primarily attacks the lungs but can infect any organ system, known as extrapulmonary TB. The bacteria are transmitted via airborne droplets when an infectious person coughs, sneezes, or speaks. Once inhaled, the bacteria can establish a latent infection, where the immune system walls them off, or progress to active TB disease, characterized by symptoms like a persistent cough (sometimes with hemoptysis), fever, night sweats, and unintended weight loss.

The progression from latent to active disease is a key nursing concern. Factors such as HIV co-infection, diabetes, immunosuppressive therapy, or malnutrition significantly increase this risk. Understanding this spectrum—from exposure to latent infection to active disease—is fundamental to screening, diagnosis, and patient education. Your assessment must differentiate between latent infection, which is not contagious, and active disease, which requires immediate isolation and treatment.

Diagnostic Screening and Assessment: The Tuberculin Skin Test and Beyond

Accurate diagnosis is the first step in effective care. The tuberculin skin test (TST), also known as the Mantoux test, is a common screening tool. It involves intradermally injecting a small amount of purified protein derivative (PPD) into the forearm. The test site must be read by a trained professional 48 to 72 hours later, measuring the induration (firm swelling) in millimeters. Interpretation depends on the patient’s risk factors; for example, an induration of $\ge$10 mm may be positive for a healthcare worker, while $\ge$5 mm is positive for an HIV-positive individual.

A positive TST indicates infection with TB bacteria but cannot distinguish between latent and active disease. Further diagnostic steps for active TB include chest X-rays and, most critically, sputum collection for acid-fast bacilli (AFB) smear and culture. Sputum samples (often three collected on different days, including one early morning specimen) provide definitive diagnosis and guide drug sensitivity testing. Your role in educating the patient on proper deep-cough sputum collection is vital for accurate results.

Foundational Pillar: Implementing Airborne Precautions

For patients with suspected or confirmed active pulmonary TB, immediate implementation of airborne infection isolation precautions is non-negotiable. This protocol protects healthcare workers, other patients, and visitors. The patient must be placed in a negative pressure airborne infection isolation room (AIIR), which exhausts air to the outside or through HEPA filtration.

The cornerstone of personal protective equipment (PPE) is the N95 respirator. A simple surgical mask is insufficient. You must undergo annual fit-testing to ensure a proper seal and be user-seal checked every time you don the respirator. Anyone entering the room must wear a properly fitted N95. Patients should wear a surgical mask when transported outside the isolation room. These precautions are maintained until the patient is on effective therapy, shows clinical improvement, and has three consecutive negative AFB sputum smears collected at least 8 hours apart. This rigorous standard underscores your responsibility in preventing nosocomial outbreaks.

Core Clinical Intervention: Administering and Monitoring Multi-Drug Therapy

Treatment for active TB disease involves a multi-drug regimen, typically starting with a four-drug combination: isoniazid (INH), rifampin (RIF), pyrazinamide (PZA), and ethambutol (EMB). This initial phase lasts two months, followed by a continuation phase of INH and RIF for four more months. Medication adherence is the single most important determinant of cure and preventing the development of drug-resistant TB (DR-TB), such as multidrug-resistant TB (MDR-TB).

Your nursing responsibilities are extensive:

• Administering medications: Understanding dosing, routes, and common side effects.
• Monitoring for adverse effects: Vigilantly assessing for hepatotoxicity (e.g., nausea, vomiting, jaundice, abdominal pain, fatigue), which is associated with INH, RIF, and PZA. Baseline and periodic liver function tests are required. Also monitor for other toxicities like rifampin’s orange discoloration of body fluids, ethambutol’s optic neuritis (requiring baseline visual acuity testing), and pyrazinamide-induced hyperuricemia.
• Patient education: Teach patients about the necessity of completing the full course, potential side effects to report, and the importance of not sharing medications.

To maximize adherence, directly observed therapy (DOT) is the standard of care. In DOT, a healthcare worker or trained designee observes the patient swallowing every dose of medication. As a nurse, you may administer DOT or coordinate these programs, which significantly improve completion rates and reduce community transmission.

Public Health and Psychosocial Coordination

TB nursing extends beyond the bedside. Tuberculosis is a reportable disease; you have a legal and ethical obligation to report suspected or confirmed cases to local public health authorities promptly. This triggers a contact investigation, where public health workers identify and screen individuals who were exposed to the infectious patient. Nurses often play a key role in educating the index patient about this process and alleviating fears.

Your psychosocial support is crucial. Patients may face stigma, fear, and isolation due to their diagnosis and lengthy treatment. Employ therapeutic communication to address anxiety, provide emotional support, and connect patients with social services for needs like housing or nutrition, which directly impact treatment success. For patients with latent TB infection, educating them about the benefits of preventive therapy (e.g., with INH) to avoid progressing to active disease is a key preventive nursing function.

Common Pitfalls

1. Inadequate Airborne Precautions: Using a surgical mask instead of a fit-tested N95 respirator or discontinuing isolation too early. Correction: Strictly adhere to CDC/NIOSH guidelines for respiratory protection. Maintain isolation until clinical and microbiological criteria are met, not just based on the start of therapy.

1. Missing Signs of Hepatotoxicity: Attributing early symptoms like nausea or fatigue to minor causes. Correction: Proactively educate patients to report these symptoms immediately. Schedule and review liver function tests as ordered, understanding that asymptomatic elevation of liver enzymes can occur and may not always require cessation of therapy, but must be evaluated.

1. Overlooking DOT or Adherence Counseling: Assuming a reliable patient will take medications correctly for six months without support. Correction: Advocate for and utilize DOT for all patients with active TB. Frame it as a supportive service, not a punitive measure, and provide consistent, non-judgmental adherence counseling.

1. Failing to Initiate Public Health Reporting: Seeing reporting as an administrative task rather than a core infection control intervention. Correction: Report immediately upon suspicion. Your prompt action initiates contact investigations that prevent further spread in the community.

Summary

• TB nursing requires mastery of two parallel tracks: strict airborne precautions (AIIR, N95 respirators) to prevent transmission and meticulous management of multi-drug therapy to cure the disease.
• Accurate diagnosis hinges on interpreting tests like the tuberculin skin test (TST) and ensuring proper sputum collection, while monitoring focuses heavily on detecting hepatotoxicity and other drug toxicities.
• Directly observed therapy (DOT) is the evidence-based standard to ensure treatment completion and prevent drug resistance.
• Your role is legally bound to public health reporting, which triggers essential contact investigations, and is holistically completed by providing psychosocial support to mitigate the stigma and challenges of a TB diagnosis.